About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 96 record(s)
Req # A-2021-001594
Adverse Drug Reactions (ADRs). Report numbers: E2B_04577297, E2B_04515106, E2B_02989790, E2B_03366429, E2B_04507554, E2B_04524456, E2B_04610347, E2B_04594121, E2B_04563399, E2B_04588474, 000965761, 000965330, 000968574, 000964232.Organization: Health Canada
April 2022
Req # A-2021-001612
Adverse Drug Reactions (ADRs). Report numbers: E2B_04384252, E2B_04399321, E2B_04404900, 000959260, E2B_04394549.Organization: Health Canada
April 2022
Req # A-2021-001619
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_04134477, E2B_04134477, E2B_04107969, E2B_04358045, E2B_04295881, E2B_04350808, E2B_04247642, E2B_04290432, 000963739, E2B_04284263.Organization: Health Canada
April 2022
Req # A-2021-001646
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: 04460246, E2B_03706333.Organization: Health Canada
April 2022
Req # A-2021-001658
Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: 967801.Organization: Health Canada
April 2022
Req # A-2021-001662
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_04557963, 960451, 960167, 963452, 960477, 960529, 963712, 963526, 961172, 963642, 966512, 966516, 964791, 965536, 964704, 967173, 967365, 967612, 964731, 964788.Organization: Health Canada
April 2022
Req # A-2021-001680
Adverse Drug Reaction (ADR) for Glyceryl Trinitate. Report number: E2B_04384481.Organization: Health Canada
April 2022
Req # A-2021-001702
Adverse Drug Reaction (ADR) for TERIFLUNOMIDE. Report number: E2B_04262126.Organization: Health Canada
April 2022
Req # A-2021-001716
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-119382-207.Organization: Health Canada
April 2022
Req # A-2021-001751
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-119382-207.Organization: Health Canada
April 2022